Direct Buyers Win Cert. In Lamictal Antitrust Suit
Drug wholesalers who directly purchased GlaxoSmithKline PLC's epilepsy drug Lamictal or a generic version from Teva Pharmaceutical Industries Ltd. won certification Wednesday in their antitrust suit alleging a settlement agreement struck...To view the full article, register now.
Already a subscriber? Click here to view full article